Heterologous Expression of a VioA Variant Activates Cryptic Compounds in a Marine-Derived Brevibacterium Strain

A new 14-membered homodimeric macrodiolide, brevidiolide (3), along with four known aromatic compounds (1, 2, 4 and 5) were obtained by heterologous expression of the recombinant plasmid pWLI823 expressing the G231L variant of VioA in the marine-derived Brevibacterium sp. 7002-073. The structures of...

Full description

Bibliographic Details
Published in:Marine Drugs
Main Authors: Xiao Han, Lukuan Hou, Jing Hou, Yongyu Zhang, Huayue Li, Wenli Li
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Subjects:
heterologous expression
recombinant
Brevibacterium
macrodiolide
antibacterial
Online Access:http://www.mdpi.com/1660-3397/16/6/191
Description
Summary:A new 14-membered homodimeric macrodiolide, brevidiolide (3), along with four known aromatic compounds (1, 2, 4 and 5) were obtained by heterologous expression of the recombinant plasmid pWLI823 expressing the G231L variant of VioA in the marine-derived Brevibacterium sp. 7002-073. The structures of 1–5 were elucidated on the basis of LC-MS and 2D NMR spectroscopic analyses. In the evaluation for the antibacterial activities of the compounds against multi-drug resistant (MDR) strains, 5 showed notable growth inhibition against Staphylococcus aureus CCARM 3090 and Klebsiella pneumoniae ATCC 13883, with a minimum inhibitory concentration (MIC) value of 3.12 µg/mL.
ISSN:1660-3397

Similar Items